# EDGAR Filing Document

**Accession Number:** 0001944885
**File Stem:** 0000950170-25-113757
**Filing Date:** 2025-9
**Character Count:** 7904
**Document Hash:** 700102446747ad1e657b559be4766611
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000950170-25-113757.hdr.sgml**: 20250909

**ACCESSION NUMBER**: 0000950170-25-113757

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250909

**DATE AS OF CHANGE**: 20250909

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Apollomics Inc.
- **CENTRAL INDEX KEY:** 0001944885
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-94041
- **FILM NUMBER:** 251302486

**BUSINESS ADDRESS:**
- **STREET 1:** 989 EAST HILLSDALE BLVD.
- **STREET 2:** STE 220
- **CITY:** FOSTER CITY
- **STATE:** CA
- **ZIP:** 94404
- **BUSINESS PHONE:** 1-650-209-4055

**MAIL ADDRESS:**
- **STREET 1:** 989 EAST HILLSDALE BLVD.
- **STREET 2:** STE 220
- **CITY:** FOSTER CITY
- **STATE:** CA
- **ZIP:** 94404
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Chen Hung-Wen
- **CENTRAL INDEX KEY:** 0002023674

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D

**MAIL ADDRESS:**
- **STREET 1:** NO. 6, LANE 8, QINGTIAN ST., DA'AN DIST.
- **CITY:** TAIPEI CITY 106
- **STATE:** F5
- **ZIP:** 4F

### Attached PDF Documents

**Attachment 1:** `ck0000000000-ex99_a.pdf`

_No text found in this document._

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**Apollomics Inc.**

*(Name of Issuer)*

**Class A ordinary shares, par value $0.0001 per share**

*(Title of Class of Securities)*

**G0411D123**

*(CUSIP Number)*

**Hung-Wen Chen**<br>4F, No. 6, Lane 8, Qingtian Street<br>Da'an District<br>Taipei City F5 106<br>886932033081

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**09/03/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **G0411D123** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Hung-Wen Chen** | Name of reporting person<br>**Hung-Wen Chen** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**F5** | Citizenship or place of organization<br>**F5** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**133334.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**896362.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**133334.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**896362.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**896362.00** | Aggregate amount beneficially owned by each reporting person<br>**896362.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**41.8%** | Percent of class represented by amount in Row (11)<br>**41.8%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

| **CUSIP No.** | **G0411D123** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**King Regent Management Limited** | Name of reporting person<br>**King Regent Management Limited** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**T2** | Citizenship or place of organization<br>**T2** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**763028.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**896362.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**763028.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**896362.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**896362.00** | Aggregate amount beneficially owned by each reporting person<br>**896362.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**41.8%** | Percent of class represented by amount in Row (11)<br>**41.8%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Class A ordinary shares, par value $0.0001 per share

**(b) Name of Issuer:**
Apollomics Inc.

**(c) Address of Issuer's Principal Executive Offices:**
989 E. Hillsdale Blvd., Suite 220, Foster City, CA, 94404

On September 2, 2025, the Issuer entered into subscription agreements (the "PIPE Subscription Agreements") with certain accredited investors, including King Regent Management Limited and Hung-Wen (Howard) Chen, the terms of which are disclosed by the Issuer on Form 6-K filed with the SEC on September 3, 2025, and is incorporated herein by reference.

As disclosed by the Form 20-F filed on April 3rd, 2025, and the Form 6-K filed on September 3rd, 2025, the total outstanding shares of the Issuer are 2146151 shares.

Explanatory Note: the previous Schedule 13G as filed by Hung-Wen Chen with the SEC on date May 20, 2024, is hereby amended and updated by this Schedule 13D, based on the information contained herein.

**Item 4. Purpose of Transaction**

Investment

**Item 5. Interest in Securities of the Issuer**

**(a)**
896,362,    41.8%

**(b)**
2146151

**(c)**
PIPE investment

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

Mr. Chen being the sole owner and director of King Regent

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Hung-Wen Chen

**Signature:** /s/ Hung-Wen Chen

**Name/Title:** Hung-Wen Chen, Director

**Date:** 09/09/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** King Regent Management Limited

**Signature:** /s/ Hung-Wen Chen

**Name/Title:** Hung-Wen Chen, Director

**Date:** 09/09/2025